Alteplase for stroke

BMJ

Volumn 324, Issue 7353, 2002, Pages 1581-

  Mann, Howard ^a   li, James ^b   Nathanson, Larry A ^b   Mills, Trevor J ^c   Netland, Karin E ^d   Paula, Richard ^e   Ragland, Douglas ^f   Faxon, David ^g   Solomon, Robert C ^h   Hoffman, Jerome R ⁱ   Lenzer, Jeanne ^j   Saver, Jeffrey L ⁱ   Kidwell, Chelsea S ⁱ   Starkman, Sidney ⁱ  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f John C Lincoln Hospital   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h Ohio Valley Medical Center   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Oak Ridge Journalism   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

CEREBROVASCULAR ACCIDENT; HUMAN; NOTE; TREATMENT OUTCOME;

CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 85007669247     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.324.7353.1581     Document Type: Letter

References (17)

1. Lenzer L. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign [commentaries by C Warlow; JL Saver, CS Kidwell, S Starkman]. BMJ 2002; 324: 723–729. (23 March.)
2. Emanuel E, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283: 2701–2711.
3. ASSERT. A standard for the scientific and ethical review of trials. www.assert-statement.org/publication.html#resultsdissem
4. Lenzer L. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign [commentaries by C Warlow; JL Saver, CS Kidwell, S Starkman]. BMJ 2002; 324: 723–729. (23 March.)
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Lancet 1999; 354: 1896–1900.
6. Lenzer L. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign [commentaries by C Warlow; JL Saver, CS Kidwell, S Starkman]. BMJ 2002; 324: 723–729. (23 March.)
7. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2000; 102(8 suppl). [Whole supplement.]
8. Proceedings of the guidelines 2000 conference for cardiopulmonary resuscitation and emergency cardiovascular care: an international consensus on science. Ann Emerg Med 2001; 37(4 suppl):S1–200.
9. Lenzer L. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign [commentaries by C Warlow; JL Saver, CS Kidwell, S Starkman]. BMJ 2002; 324: 723–729. (23 March.)
10. Lenzer L. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign [commentaries by C Warlow; JL Saver, CS Kidwell, S Starkman]. BMJ 2002; 324: 723–729. (23 March.)
11. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002; 346: 1901–1902.
12. Rennie D. Thyroid storm. JAMA 1997; 277: 1238–1243.
13. Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 1997; 277: 1205–1213.
14. Haley Jr EC, Lewandowski C, Tilley BC. Myths regarding the NINDS rt-PA stroke trial: setting the record straight. Ann Emerg Med 1997; 30: 676–682.
15. FDA Center for Biologics Evaluation and Research. Clinical review for PLA 96–0350. 12 June 1996.
16. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283: 3102–3109.
17. American College of Emergency Physicians Board of Directors. Policy statement: Use of intravenous tPA for the management of acute stroke in the emergency department. Published February 2002. Available at: www.acep.org/1,5006,0.html; accessed 16 May 2002.